Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05909605 · ClinicalTrials.gov registry record
Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 150
- Enrollment target
NCT05909605: Completed study, sponsored by University of California, San Diego.
NCT05909605 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05909605 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.
Primary Outcome
Clinical feasibility of the calibration accuracy of the non-invasive ultrasound blood pressure sensor in comparison to a sphygmomanometer on 10 participants.
Interventions
- DEVICE sphygmomanometer
- DEVICE Arterial Line
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2023-12-02 |
What the finished NCT05909605 record still lists
NCT05909605 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which sphygmomanometer is the first listed.
NCT05909605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05909605 about?
NCT05909605 is a clinical study titled "Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor". Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently i...
What is the current status of trial NCT05909605?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2020-10-20. Estimated completion is 2023-12-02.
What interventions are being tested in trial NCT05909605?
The interventions under investigation include: sphygmomanometer (DEVICE), Arterial Line (DEVICE).
Who is sponsoring clinical trial NCT05909605?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI